Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus. [electronic resource]
Producer: 20141223Description: 684-90 p. digitalISSN:- 1476-5365
- Adult
- Aged
- Drug Therapy, Combination
- Female
- Graft vs Host Disease -- drug therapy
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunosuppressive Agents -- administration & dosage
- Incidence
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Multivariate Analysis
- Prognosis
- Retrospective Studies
- Risk Factors
- Sirolimus -- administration & dosage
- Tacrolimus -- administration & dosage
- Thrombotic Microangiopathies -- epidemiology
- Transplantation, Homologous
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.